Methods and reagents relating to inflammation and apoptosis
OwnerJun Kuai, Lih-Ling Lin +2inventors
InventorsJun Kuai, Lih-Ling Lin, Joseph Wooters, Elliott Nickbarg
Life of this patent
Estimating the term…
Loading patent…
OwnerJun Kuai, Lih-Ling Lin +2inventors
InventorsJun Kuai, Lih-Ling Lin, Joseph Wooters, Elliott Nickbarg
Estimating the term…
The present invention relates to, among other embodiments, protein complexes which include tumor necrosis factor alpha (TNF-α) and/or tumor necrosis factor alpha receptor (TNFR). Preferably, the complexes comprise at least one polypeptide selected from the group consisting of: NF-κB activating kinase (NAK), RasGAP3, TRCP1, and TRCP2. The present invention further provides assays of identifying a compound for modulating the stability and activity of the complex. Also provided are methods of modulating apoptosis and inflammation, as well as treating TNF-α related diseases.
An isolated, purified, or recombinant protein complex comprising:
13-16. (canceled)
An isolated, purified, or recombinant protein complex comprising:
18-21. (canceled)
26-32. (canceled)
A host cell comprising a first nucleic acid, a second nucleic acid and a third nucleic acid, wherein the first nucleic acid comprises a recombinant nucleic acid encoding a TNF-α polypeptide, wherein the second nucleic acid comprises a recombinant nucleic acid encoding a TNFR polypeptide and wherein the third nucleic acid comprises a recombinant nucleic acid encoding a polypeptide selected from the group consisting of:
A host cell comprising a first nucleic acid and a second nucleic acid, wherein the first nucleic acid comprises a recombinant nucleic acid encoding a TNFR, and wherein the second nucleic acid comprises a recombinant nucleic acid encoding a polypeptide selected from the group consisting of:
An assay for identifying a test compound which inhibits or potentiates the stability of a complex, comprising:
(canceled)
An assay for identifying a test compound which inhibits or potentiates the stability of a complex, comprising:
40-43. (canceled)
A method for modulating, in a cell, a protein complex comprising at least a first protein and a second protein, wherein said first protein is TNFR, and wherein said second protein is selected from the group consisting of:
A method of producing a functional complex comprising:
A method for treating a TNF-α-related disorder, by administering an effective amount of a compound that inhibits the interaction of TNF-α or TNFR with a polypeptide selected from the group consisting of:
A method of identifying a test compound that is a candidate modulator of inflammation or apoptosis, the method comprising:
A method of identifying a test compound that is a candidate modulator of inflammation or apoptosis, the method comprising:
A method of treating a TNF-α-related disease which includes an inflammatory or apoptotic component, by administering an effective amount of a therapeutic composition that modulates TRCP1 or TRCP2.
(canceled)
Dependencies are inferred from the claim text.